Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
C1QL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LGR4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CAND1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
YLPM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PDIK1L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SYNCRIP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GRPEL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC729296 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
ACAN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OSTM1-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DNAJC3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATXN7L1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BEX5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NDFIP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPP2R2C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on